25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

PharmX Technologies Limited
Buy, Hold or Sell?

Let's analyze Pharmx together

I guess you are interested in PharmX Technologies Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PharmX Technologies Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about PharmX Technologies Limited

I send you an email if I find something interesting about PharmX Technologies Limited.

Quick analysis of Pharmx (30 sec.)










What can you expect buying and holding a share of Pharmx? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
A$0.04
Expected worth in 1 year
A$0.03
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-13.3%

For what price can you sell your share?

Current Price per Share
A$0.05
Expected price per share
A$0.05 - A$0.061
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Pharmx (5 min.)




Live pricePrice per Share (EOD)

A$0.05

Intrinsic Value Per Share

A$-0.10 - A$-0.02

Total Value Per Share

A$-0.06 - A$0.01

2. Growth of Pharmx (5 min.)




Is Pharmx growing?

Current yearPrevious yearGrowGrow %
How rich?$14.5m$15.2m-$649.8k-4.5%

How much money is Pharmx making?

Current yearPrevious yearGrowGrow %
Making money-$688.5k$165k-$853.5k-124.0%
Net Profit Margin-17.5%2.1%--

How much money comes from the company's main activities?

3. Financial Health of Pharmx (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  

3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Pharmx? (5 min.)

Welcome investor! Pharmx's management wants to use your money to grow the business. In return you get a share of Pharmx.

What can you expect buying and holding a share of Pharmx?

First you should know what it really means to hold a share of Pharmx. And how you can make/lose money.

Speculation

The Price per Share of Pharmx is A$0.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharmx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharmx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.04. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharmx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-2.3%0.00-2.3%0.000.6%0.00-1.6%0.00-0.1%
Usd Book Value Change Per Share0.00-2.2%0.00-2.2%0.000.6%0.003.5%0.001.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.001.2%0.002.1%
Usd Total Gains Per Share0.00-2.2%0.00-2.2%0.000.6%0.004.7%0.003.3%
Usd Price Per Share0.02-0.02-0.02-0.03-0.04-
Price to Earnings Ratio-21.07--21.07-80.75-48.42-264.35-
Price-to-Total Gains Ratio-22.32--22.32-74.54-11.60--261.14-
Price to Book Ratio1.00-1.00-0.88-1.54-2.20-
Price-to-Total Gains Ratio-22.32--22.32-74.54-11.60--261.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.032755
Number of shares30529
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (30529 shares)-33.1571.32
Gains per Year (30529 shares)-132.59285.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-133-14372213275
20-265-276144427560
30-398-409216640845
40-530-5422878541130
50-663-67535910671415
60-796-80843112811700
70-928-94150314941985
80-1061-107457517072270
90-1193-120764719212555
100-1326-134071921342840

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%13.013.06.040.6%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%6.04.00.060.0%18.014.00.056.3%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%6.00.04.060.0%11.00.021.034.4%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%6.04.00.060.0%18.014.00.056.3%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Pharmx

About PharmX Technologies Limited

PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. The company's network connects retail pharmacy and suppliers in Australia and New Zealand. It operates PharmX, an electronic pharmacy ordering gateway; and PharmXchange, a digital sales and marketing platform integrated with PharmX for pharmacies and their suppliers. The company was formerly known as Corum Group Limited and changed its name to PharmX Technologies Limited in October 2023. PharmX Technologies Limited was incorporated in 1950 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-07-16 17:22:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of PharmX Technologies Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pharmx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pharmx to the Health Information Services industry mean.
  • A Net Profit Margin of -17.5% means that $-0.17 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PharmX Technologies Limited:

  • The MRQ is -17.5%. The company is making a huge loss. -2
  • The TTM is -17.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-17.5%TTM-17.5%0.0%
TTM-17.5%YOY2.1%-19.6%
TTM-17.5%5Y-9.3%-8.2%
5Y-9.3%10Y-3.9%-5.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.5%-16.8%-0.7%
TTM-17.5%-23.0%+5.5%
YOY2.1%-27.6%+29.7%
5Y-9.3%-33.6%+24.3%
10Y-3.9%-43.2%+39.3%
1.1.2. Return on Assets

Shows how efficient Pharmx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pharmx to the Health Information Services industry mean.
  • -2.9% Return on Assets means that Pharmx generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PharmX Technologies Limited:

  • The MRQ is -2.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.9%TTM-2.9%0.0%
TTM-2.9%YOY0.8%-3.7%
TTM-2.9%5Y-5.1%+2.2%
5Y-5.1%10Y-2.1%-3.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.9%-3.9%+1.0%
TTM-2.9%-4.9%+2.0%
YOY0.8%-5.8%+6.6%
5Y-5.1%-6.3%+1.2%
10Y-2.1%-7.2%+5.1%
1.1.3. Return on Equity

Shows how efficient Pharmx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pharmx to the Health Information Services industry mean.
  • -4.7% Return on Equity means Pharmx generated $-0.05 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PharmX Technologies Limited:

  • The MRQ is -4.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.7%TTM-4.7%0.0%
TTM-4.7%YOY1.1%-5.8%
TTM-4.7%5Y-7.9%+3.2%
5Y-7.9%10Y-3.4%-4.5%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.7%-3.6%-1.1%
TTM-4.7%-5.7%+1.0%
YOY1.1%-8.3%+9.4%
5Y-7.9%-9.4%+1.5%
10Y-3.4%-9.5%+6.1%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of PharmX Technologies Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pharmx is operating .

  • Measures how much profit Pharmx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pharmx to the Health Information Services industry mean.
  • An Operating Margin of -11.1% means the company generated $-0.11  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PharmX Technologies Limited:

  • The MRQ is -11.1%. The company is operating very inefficient. -2
  • The TTM is -11.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-11.1%TTM-11.1%0.0%
TTM-11.1%YOY3.1%-14.1%
TTM-11.1%5Y13.0%-24.1%
5Y13.0%10Y10.1%+3.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.1%-26.4%+15.3%
TTM-11.1%-12.5%+1.4%
YOY3.1%-23.9%+27.0%
5Y13.0%-18.9%+31.9%
10Y10.1%-26.5%+36.6%
1.2.2. Operating Ratio

Measures how efficient Pharmx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 1.18 means that the operating costs are $1.18 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of PharmX Technologies Limited:

  • The MRQ is 1.177. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.177. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.177TTM1.1770.000
TTM1.177YOY1.153+0.024
TTM1.1775Y1.120+0.057
5Y1.12010Y1.021+0.099
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1771.369-0.192
TTM1.1771.377-0.200
YOY1.1531.403-0.250
5Y1.1201.372-0.252
10Y1.0211.373-0.352
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of PharmX Technologies Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pharmx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 1.84 means the company has $1.84 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of PharmX Technologies Limited:

  • The MRQ is 1.838. The company is able to pay all its short-term debts. +1
  • The TTM is 1.838. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.838TTM1.8380.000
TTM1.838YOY1.679+0.159
TTM1.8385Y1.770+0.068
5Y1.77010Y1.957-0.186
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8381.771+0.067
TTM1.8381.691+0.147
YOY1.6792.151-0.472
5Y1.7702.714-0.944
10Y1.9572.635-0.678
1.3.2. Quick Ratio

Measures if Pharmx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pharmx to the Health Information Services industry mean.
  • A Quick Ratio of 2.14 means the company can pay off $2.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PharmX Technologies Limited:

  • The MRQ is 2.139. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.139. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.139TTM2.1390.000
TTM2.139YOY2.365-0.226
TTM2.1395Y1.548+0.591
5Y1.54810Y1.554-0.006
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1391.141+0.998
TTM2.1391.154+0.985
YOY2.3651.813+0.552
5Y1.5482.296-0.748
10Y1.5542.251-0.697
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of PharmX Technologies Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pharmx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pharmx to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.39 means that Pharmx assets are financed with 39.2% credit (debt) and the remaining percentage (100% - 39.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PharmX Technologies Limited:

  • The MRQ is 0.392. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.392. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.392TTM0.3920.000
TTM0.392YOY0.246+0.146
TTM0.3925Y0.310+0.081
5Y0.31010Y0.293+0.017
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3920.380+0.012
TTM0.3920.393-0.001
YOY0.2460.390-0.144
5Y0.3100.414-0.104
10Y0.2930.437-0.144
1.4.2. Debt to Equity Ratio

Measures if Pharmx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pharmx to the Health Information Services industry mean.
  • A Debt to Equity ratio of 64.4% means that company has $0.64 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PharmX Technologies Limited:

  • The MRQ is 0.644. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.644. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.644TTM0.6440.000
TTM0.644YOY0.326+0.318
TTM0.6445Y0.458+0.186
5Y0.45810Y0.421+0.037
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6440.556+0.088
TTM0.6440.574+0.070
YOY0.3260.621-0.295
5Y0.4580.695-0.237
10Y0.4210.615-0.194
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of PharmX Technologies Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pharmx generates.

  • Above 15 is considered overpriced but always compare Pharmx to the Health Information Services industry mean.
  • A PE ratio of -21.07 means the investor is paying $-21.07 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PharmX Technologies Limited:

  • The EOD is -28.473. Based on the earnings, the company is expensive. -2
  • The MRQ is -21.070. Based on the earnings, the company is expensive. -2
  • The TTM is -21.070. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-28.473MRQ-21.070-7.403
MRQ-21.070TTM-21.0700.000
TTM-21.070YOY80.751-101.821
TTM-21.0705Y48.422-69.492
5Y48.42210Y264.354-215.932
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-28.473-1.805-26.668
MRQ-21.070-2.277-18.793
TTM-21.070-1.942-19.128
YOY80.751-2.982+83.733
5Y48.422-6.531+54.953
10Y264.354-5.143+269.497
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PharmX Technologies Limited:

  • The EOD is -8.909. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.593. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.593. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.909MRQ-6.593-2.316
MRQ-6.593TTM-6.5930.000
TTM-6.593YOY-11.419+4.827
TTM-6.5935Y-8.633+2.040
5Y-8.63310Y-4.551-4.082
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-8.909-2.535-6.374
MRQ-6.593-3.165-3.428
TTM-6.593-2.000-4.593
YOY-11.419-5.137-6.282
5Y-8.633-6.570-2.063
10Y-4.551-4.072-0.479
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pharmx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 1.00 means the investor is paying $1.00 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of PharmX Technologies Limited:

  • The EOD is 1.347. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.997. Based on the equity, the company is cheap. +2
  • The TTM is 0.997. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.347MRQ0.997+0.350
MRQ0.997TTM0.9970.000
TTM0.997YOY0.877+0.120
TTM0.9975Y1.538-0.541
5Y1.53810Y2.201-0.662
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD1.3471.629-0.282
MRQ0.9971.836-0.839
TTM0.9971.911-0.914
YOY0.8772.566-1.689
5Y1.5384.669-3.131
10Y2.2014.500-2.299
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of PharmX Technologies Limited.

3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of PharmX Technologies Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.002-0.0020%0.000-463%0.003-162%0.001-269%
Book Value Per Share--0.0370.0370%0.039-4%0.031+21%0.030+24%
Current Ratio--1.8381.8380%1.679+9%1.770+4%1.957-6%
Debt To Asset Ratio--0.3920.3920%0.246+59%0.310+26%0.293+34%
Debt To Equity Ratio--0.6440.6440%0.326+98%0.458+41%0.421+53%
Dividend Per Share----0%-0%0.001-100%0.002-100%
Eps---0.002-0.0020%0.000-517%-0.001-29%0.000-96%
Free Cash Flow Per Share---0.006-0.0060%-0.003-47%-0.005-5%-0.002-57%
Free Cash Flow To Equity Per Share---0.006-0.0060%-0.004-42%-0.001-81%0.000-96%
Gross Profit Margin--1.1641.1640%-0.048+104%0.284+309%-1.561+234%
Intrinsic Value_10Y_max---0.023--------
Intrinsic Value_10Y_min---0.101--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.007--------
Intrinsic Value_3Y_max---0.007--------
Intrinsic Value_3Y_min---0.023--------
Intrinsic Value_5Y_max---0.012--------
Intrinsic Value_5Y_min---0.043--------
Market Cap29925350.400+26%22144759.29622144759.2960%20349238.272+9%27196158.444-19%40093984.466-45%
Net Profit Margin---0.175-0.1750%0.021-926%-0.093-47%-0.039-78%
Operating Margin---0.111-0.1110%0.031-457%0.130-185%0.101-210%
Operating Ratio--1.1771.1770%1.153+2%1.120+5%1.021+15%
Pb Ratio1.347+26%0.9970.9970%0.877+14%1.538-35%2.201-55%
Pe Ratio-28.473-35%-21.070-21.0700%80.751-126%48.422-144%264.354-108%
Price Per Share0.050+26%0.0370.0370%0.034+9%0.045-19%0.067-45%
Price To Free Cash Flow Ratio-8.909-35%-6.593-6.5930%-11.419+73%-8.633+31%-4.551-31%
Price To Total Gains Ratio-30.167-35%-22.323-22.3230%74.539-130%11.595-293%-261.139+1070%
Quick Ratio--2.1392.1390%2.365-10%1.548+38%1.554+38%
Return On Assets---0.029-0.0290%0.008-451%-0.051+78%-0.021-26%
Return On Equity---0.047-0.0470%0.011-536%-0.079+67%-0.034-29%
Total Gains Per Share---0.002-0.0020%0.000-463%0.004-146%0.003-165%
Usd Book Value--14550426.10014550426.1000%15200285.300-4%11996584.260+21%11692159.290+24%
Usd Book Value Change Per Share---0.001-0.0010%0.000-463%0.002-162%0.001-269%
Usd Book Value Per Share--0.0240.0240%0.025-4%0.020+21%0.020+24%
Usd Dividend Per Share----0%-0%0.001-100%0.001-100%
Usd Eps---0.001-0.0010%0.000-517%-0.001-29%0.000-96%
Usd Free Cash Flow---2200480.900-2200480.9000%-1167388.200-47%-2086624.520-5%-949763.980-57%
Usd Free Cash Flow Per Share---0.004-0.0040%-0.002-47%-0.003-5%-0.002-57%
Usd Free Cash Flow To Equity Per Share---0.004-0.0040%-0.002-42%-0.001-81%0.000-96%
Usd Market Cap19604097.047+26%14507031.81514507031.8150%13330785.992+9%17816203.396-19%26265569.224-45%
Usd Price Per Share0.033+26%0.0240.0240%0.022+9%0.030-19%0.044-45%
Usd Profit---688510.100-688510.1000%165085.200-517%-489621.740-29%-28300.320-96%
Usd Revenue--3942391.8003942391.8000%7810102.200-50%6536587.800-40%8314136.140-53%
Usd Total Gains Per Share---0.001-0.0010%0.000-463%0.002-146%0.002-165%
 EOD+5 -3MRQTTM+0 -0YOY+6 -285Y+11 -2510Y+10 -26

4.2. Fundamental Score

Let's check the fundamental score of PharmX Technologies Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-28.473
Price to Book Ratio (EOD)Between0-11.347
Net Profit Margin (MRQ)Greater than0-0.175
Operating Margin (MRQ)Greater than0-0.111
Quick Ratio (MRQ)Greater than12.139
Current Ratio (MRQ)Greater than11.838
Debt to Asset Ratio (MRQ)Less than10.392
Debt to Equity Ratio (MRQ)Less than10.644
Return on Equity (MRQ)Greater than0.15-0.047
Return on Assets (MRQ)Greater than0.05-0.029
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of PharmX Technologies Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.249
Ma 20Greater thanMa 500.052
Ma 50Greater thanMa 1000.040
Ma 100Greater thanMa 2000.036
OpenGreater thanClose0.050
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
EBIT  4,009-2,0341,975-4801,495-1,126369-1,034-665
Operating Income  4,009-2,0341,975-4801,495-1,126369-1,034-665
Total Other Income Expense Net -7,9926,475-1,5171,381-13665-71361290
Discontinued Operations  234023402340234-402-168



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets36,520
Total Liabilities14,309
Total Stockholder Equity22,211
 As reported
Total Liabilities 14,309
Total Stockholder Equity+ 22,211
Total Assets = 36,520

Assets

Total Assets36,520
Total Current Assets22,589
Long-term Assets13,931
Total Current Assets
Cash And Cash Equivalents 12,806
Short-term Investments 12,536
Net Receivables 946
Total Current Assets  (as reported)22,589
Total Current Assets  (calculated)26,288
+/- 3,699
Long-term Assets
Property Plant Equipment 47
Goodwill 2,115
Intangible Assets 11,244
Other Assets 525
Long-term Assets  (as reported)13,931
Long-term Assets  (calculated)13,931
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,290
Long-term Liabilities2,019
Total Stockholder Equity22,211
Total Current Liabilities
Short-term Debt 32
Accounts payable 670
Other Current Liabilities 10,671
Total Current Liabilities  (as reported)12,290
Total Current Liabilities  (calculated)11,373
+/- 917
Long-term Liabilities
Other Liabilities 2,019
Long-term Liabilities  (as reported)2,019
Long-term Liabilities  (calculated)2,019
+/-0
Total Stockholder Equity
Common Stock98,405
Retained Earnings -76,253
Other Stockholders Equity 59
Total Stockholder Equity (as reported)22,211
Total Stockholder Equity (calculated)22,211
+/-0
Other
Capital Stock98,405
Cash and Short Term Investments 12,806
Common Stock Shares Outstanding 596,757
Current Deferred Revenue917
Liabilities and Stockholders Equity 36,520
Net Debt -12,774
Net Invested Capital 22,211
Net Tangible Assets 8,852
Net Working Capital 10,299
Property Plant and Equipment Gross 719
Short Long Term Debt Total 32



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301995-06-301994-06-301993-06-301992-06-301991-06-301990-06-301989-06-30
> Total Assets 
5,284
5,913
6,631
6,606
9,948
14,607
10,644
17,802
14,595
18,033
7,902
23,576
13,699
10,808
10,319
8,011
23,077
26,776
27,013
19,011
19,801
19,888
20,280
25,316
27,244
27,254
26,029
19,757
19,726
15,038
19,178
31,347
30,769
36,520
36,52030,76931,34719,17815,03819,72619,75726,02927,25427,24425,31620,28019,88819,80119,01127,01326,77623,0778,01110,31910,80813,69923,5767,90218,03314,59517,80210,64414,6079,9486,6066,6315,9135,284
   > Total Current Assets 
1,532
2,205
2,306
2,171
2,270
6,867
4,296
7,752
4,352
1,915
1,660
2,790
4,322
2,829
4,605
3,383
5,582
7,548
7,070
5,002
6,062
7,370
8,944
14,111
16,075
14,851
12,670
12,415
11,154
9,188
9,841
10,416
8,586
22,589
22,5898,58610,4169,8419,18811,15412,41512,67014,85116,07514,1118,9447,3706,0625,0027,0707,5485,5823,3834,6052,8294,3222,7901,6601,9154,3527,7524,2966,8672,2702,1712,3062,2051,532
       Cash And Cash Equivalents 
1,017
1,400
1,286
1,771
423
623
119
7,666
4,193
1,167
317
393
1,777
24
1,768
1,614
3,643
3,898
5,400
701
4,764
2,110
3,217
8,884
11,913
12,069
9,577
8,098
4,971
2,333
2,323
6,478
5,759
12,806
12,8065,7596,4782,3232,3334,9718,0989,57712,06911,9138,8843,2172,1104,7647015,4003,8983,6431,6141,768241,7773933171,1674,1937,6661196234231,7711,2861,4001,017
       Short-term Investments 
0
0
0
0
0
796
246
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,252
12,536
12,5365,252000000000000000000000000024679600000
       Net Receivables 
515
805
920
400
1,729
4,424
3,595
85
160
569
1,074
1,793
1,608
1,763
2,289
1,330
1,501
3,027
1,353
614
959
527
543
355
158
382
361
393
1,542
2,305
3,826
864
1,085
946
9461,0858643,8262,3051,5423933613821583555435279596141,3533,0271,5011,3302,2891,7631,6081,7931,074569160853,5954,4241,729400920805515
       Other Current Assets 
0
0
100
0
0
174
130
0
0
89
154
3
161
576
414
244
365
521
208
3,542
231
4,627
5,022
4,774
3,882
2,239
2,638
3,775
4,539
2,018
1,822
1,194
1,700
7,178
7,1781,7001,1941,8222,0184,5393,7752,6382,2393,8824,7745,0224,6272313,542208521365244414576161315489001301740010000
   > Long-term Assets 
3,752
3,708
4,325
4,435
7,678
7,740
6,348
10,051
10,243
16,118
6,242
20,786
9,377
7,979
5,714
4,628
17,495
19,228
19,943
14,009
13,739
12,518
11,336
11,205
11,169
12,403
13,359
7,342
8,572
5,850
9,337
20,931
22,183
13,931
13,93122,18320,9319,3375,8508,5727,34213,35912,40311,16911,20511,33612,51813,73914,00919,94319,22817,4954,6285,7147,9799,37720,7866,24216,11810,24310,0516,3487,7407,6784,4354,3253,7083,752
       Property Plant Equipment 
3,752
3,708
4,325
4,313
6,517
6,663
6,348
51
243
651
1,272
1,596
1,377
1,174
780
662
767
907
4,510
2,995
2,778
1,567
383
262
187
294
1,327
981
863
731
1,227
791
603
47
476037911,2277318639811,3272941872623831,5672,7782,9954,5109077676627801,1741,3771,5961,272651243516,3486,6636,5174,3134,3253,7083,752
       Goodwill 
0
0
0
0
893
905
0
0
0
5,467
4,910
11,660
6,071
5,266
4,541
3,826
15,363
15,363
15,363
10,821
10,821
10,821
10,821
10,821
10,821
10,821
10,821
4,544
4,544
0
0
2,115
2,115
2,115
2,1152,1152,115004,5444,54410,82110,82110,82110,82110,82110,82110,82110,82115,36315,36315,3633,8264,5415,2666,07111,6604,9105,4670009058930000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30
30
30
30
30
178
2,885
51
148
0
0148512,8851783030303030000000000000000000000000
       Intangible Assets 
0
0
0
0
191
0
0
10,000
10,000
10,000
60
7,530
1,929
1,539
252
3,826
1,270
2,904
14
14
14
12,066
10,821
10,821
10,821
10,821
10,821
837
2,688
4,472
4,674
17,170
18,610
11,244
11,24418,61017,1704,6744,4722,68883710,82110,82110,82110,82110,82112,0661414142,9041,2703,8262521,5391,9297,5306010,00010,00010,000001910000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
60
0
0
0
141
140
65
54
56
179
96
99
102
92
131
1,258
1,181
950
447
617
750
855
855
525
5258558557506174479501,1811,258131921029996179565465140141000600000000000
> Total Liabilities 
979
1,039
1,046
846
1,851
9,206
8,226
325
221
6,282
7,637
10,621
12,522
17,547
23,857
18,677
19,271
19,229
21,904
16,988
16,904
15,240
9,603
8,958
8,370
7,323
6,121
5,781
5,499
5,016
5,981
8,417
7,566
14,309
14,3097,5668,4175,9815,0165,4995,7816,1217,3238,3708,9589,60315,24016,90416,98821,90419,22919,27118,67723,85717,54712,52210,6217,6376,2822213258,2269,2061,8518461,0461,039979
   > Total Current Liabilities 
766
1,039
1,046
846
1,851
8,394
8,044
291
196
6,259
2,494
9,701
12,290
16,415
23,330
12,030
12,424
7,881
21,678
16,752
13,540
14,363
9,215
8,615
7,835
6,993
5,835
5,554
5,230
4,817
5,478
6,387
5,114
12,290
12,2905,1146,3875,4784,8175,2305,5545,8356,9937,8358,6159,21514,36313,54016,75221,6787,88112,42412,03023,33016,41512,2909,7012,4946,2591962918,0448,3941,8518461,0461,039766
       Short-term Debt 
0
0
0
0
0
796
246
0
0
0
0
0
0
4,024
9,706
2,557
6,854
469
11,742
6,919
2,786
2,650
0
0
0
0
0
0
0
0
422
280
303
32
32303280422000000002,6502,7866,91911,7424696,8542,5579,7064,02400000024679600000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
519
2,923
6,897
9,058
8,355
3,946
1,632
1,162
711
679
569
473
439
368
496
548
297
382
447
591
361
435
841
670
6708414353615914473822975484963684394735696797111,1621,6323,9468,3559,0586,8972,9235190000000000
       Other Current Liabilities 
766
1,039
1,046
680
1,141
5,171
6,622
15
26
5,438
1,974
6,778
4,538
2,463
5,269
5,528
2,062
4,452
7,189
9,076
9,657
10,694
8,297
7,686
6,896
6,141
5,296
4,970
4,595
4,080
4,469
5,572
3,887
10,671
10,6713,8875,5724,4694,0804,5954,9705,2966,1416,8967,6868,29710,6949,6579,0767,1894,4522,0625,5285,2692,4634,5386,7781,9745,43826156,6225,1711,1416801,0461,039766
   > Long-term Liabilities 
213
0
0
0
0
812
182
34
25
23
5,143
920
232
1,132
527
6,647
6,847
11,348
226
236
3,364
877
388
343
535
330
286
227
269
199
503
2,030
2,452
2,019
2,0192,4522,0305031992692272863305353433888773,36423622611,3486,8476,6475271,1322329205,1432325341828120000213
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
311
41
23
0
02341311000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
23
49
29
49
98
93
147
117
158
206
164
177
388
343
535
330
286
227
269
199
192
1,989
2,429
2,019
2,0192,4291,9891921992692272863305353433881771642061581171479398492949230000000000
> Total Stockholder Equity
4,305
4,874
5,585
5,760
8,097
5,401
2,418
17,477
14,375
11,751
265
12,955
1,177
-8,959
-13,538
-10,666
3,806
7,547
5,109
2,023
2,897
4,648
10,677
16,358
18,874
19,931
19,908
13,976
14,227
10,022
13,197
22,930
23,203
22,211
22,21123,20322,93013,19710,02214,22713,97619,90819,93118,87416,35810,6774,6482,8972,0235,1097,5473,806-10,666-13,538-8,9591,17712,95526511,75114,37517,4772,4185,4018,0975,7605,5854,8744,305
   Common Stock
588
588
588
588
666
779
3,353
16,136
16,136
35,080
36,460
55,164
61,040
61,315
65,267
73,462
74,107
77,223
77,835
85,219
85,219
85,219
85,219
85,795
86,223
86,283
86,283
86,283
86,283
86,283
89,724
98,366
98,366
98,405
98,40598,36698,36689,72486,28386,28386,28386,28386,28386,22385,79585,21985,21985,21985,21977,83577,22374,10773,46265,26761,31561,04055,16436,46035,08016,13616,1363,353779666588588588588
   Retained Earnings 
1,382
1,950
2,063
2,238
2,156
-7,324
-14,332
-17,053
-20,156
-23,330
-36,195
-44,428
-62,068
-70,274
-78,805
-84,129
-70,314
-69,906
-73,027
-83,515
-82,577
-80,805
-74,772
-69,784
-68,462
-66,603
-66,465
-72,307
-72,056
-76,261
-76,545
-75,454
-75,202
-76,253
-76,253-75,202-75,454-76,545-76,261-72,056-72,307-66,465-66,603-68,462-69,784-74,772-80,805-82,577-83,515-73,027-69,906-70,314-84,129-78,805-70,274-62,068-44,428-36,195-23,330-20,156-17,053-14,332-7,3242,1562,2382,0631,9501,382
   Capital Surplus 0000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000
   Other Stockholders Equity 
2,335
2,336
2,934
3,816
5,275
12,820
13,919
18,394
18,406
46
152
3,209
3,826
0
0
0
0
0
0
0
0
0
0
0
1,113
251
90
0
1,814
2,208
18
18
39
59
593918182,2081,8140902511,113000000000003,8263,2091524618,40618,39413,91912,8205,2753,8162,9342,3362,335



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue6,018
Cost of Revenue-1,210
Gross Profit4,8084,808
 
Operating Income (+$)
Gross Profit4,808
Operating Expense-5,872
Operating Income-665-1,064
 
Operating Expense (+$)
Research Development85
Selling General Administrative2,840
Selling And Marketing Expenses172
Operating Expense5,8723,097
 
Net Interest Income (+$)
Interest Income54
Interest Expense-54
Other Finance Cost-55
Net Interest Income55
 
Pretax Income (+$)
Operating Income-665
Net Interest Income55
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-719-955
EBIT - interestExpense = -719
-887
-997
Interest Expense54
Earnings Before Interest and Taxes (EBIT)-665-665
Earnings Before Interest and Taxes (EBITDA)329
 
After tax Income (+$)
Income Before Tax-719
Tax Provision-164
Net Income From Continuing Ops-883-883
Net Income-1,051
Net Income Applicable To Common Shares-1,051
 
Non-recurring Events
Discontinued Operations-168
Extraordinary Items-168
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,082
Total Other Income/Expenses Net290-55
 

Technical Analysis of Pharmx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharmx. The general trend of Pharmx is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharmx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PharmX Technologies Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.061.

The bearish price targets are: 0.05 > 0.05 > 0.05.

Tweet this
PharmX Technologies Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PharmX Technologies Limited. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PharmX Technologies Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PharmX Technologies Limited. The current macd is 0.00293741.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharmx price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Pharmx. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Pharmx price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
PharmX Technologies Limited Daily Moving Average Convergence/Divergence (MACD) ChartPharmX Technologies Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PharmX Technologies Limited. The current adx is 29.36.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Pharmx shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
PharmX Technologies Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of PharmX Technologies Limited. The current sar is 0.05954938.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
PharmX Technologies Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of PharmX Technologies Limited. The current rsi is 54.25. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
PharmX Technologies Limited Daily Relative Strength Index (RSI) ChartPharmX Technologies Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of PharmX Technologies Limited. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharmx price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
PharmX Technologies Limited Daily Stochastic Oscillator ChartPharmX Technologies Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of PharmX Technologies Limited. The current cci is -31.74603175.

PharmX Technologies Limited Daily Commodity Channel Index (CCI) ChartPharmX Technologies Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of PharmX Technologies Limited. The current cmo is -3.37058634.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
PharmX Technologies Limited Daily Chande Momentum Oscillator (CMO) ChartPharmX Technologies Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of PharmX Technologies Limited. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
PharmX Technologies Limited Daily Williams %R ChartPharmX Technologies Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of PharmX Technologies Limited.

PharmX Technologies Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of PharmX Technologies Limited. The current atr is 0.00211002.

PharmX Technologies Limited Daily Average True Range (ATR) ChartPharmX Technologies Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of PharmX Technologies Limited. The current obv is 1,377,915.

PharmX Technologies Limited Daily On-Balance Volume (OBV) ChartPharmX Technologies Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of PharmX Technologies Limited. The current mfi is 93.87.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
PharmX Technologies Limited Daily Money Flow Index (MFI) ChartPharmX Technologies Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for PharmX Technologies Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-03-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-25ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

PharmX Technologies Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of PharmX Technologies Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.249
Ma 20Greater thanMa 500.052
Ma 50Greater thanMa 1000.040
Ma 100Greater thanMa 2000.036
OpenGreater thanClose0.050
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pharmx with someone you think should read this too:
  • Are you bullish or bearish on Pharmx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharmx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about PharmX Technologies Limited

I send you an email if I find something interesting about PharmX Technologies Limited.


Comments

How you think about this?

Leave a comment

Stay informed about PharmX Technologies Limited.

Receive notifications about PharmX Technologies Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.